跳至主要内容
临床试验/ISRCTN76803177
ISRCTN76803177已完成不适用

A retrospective case report series of patients (post-marketing) Receiving Olanzapine IntraMuscular Outside of Product Monograph doses and indications: assessing safety and tolerability

ondon Health Sciences Centre (Canada)0 个研究点目标入组 10 人开始时间: 2006年8月31日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Patients whom have received Olanzapine IM in doses exceeding doses stated in literature or for uses not listed in the current edition of the Compendium of Pharmaceuticals and Specialties.

排除标准

  • Patients under 16 or over 70 years of age, or those whom have a documented allergy or sensitivity to olanzapine, also patients whom have used the olanzapine IM within normal dosing parameters.

研究者

发起方
ondon Health Sciences Centre (Canada)

相似试验